Targeted therapy with a selective BCL-2 inhibitor in older patients with acute myeloid leukemia
Open Access
- 1 April 2019
- journal article
- review article
- Published by Elsevier in Hematology, Transfusion and Cell Therapy
- Vol. 41 (2) , 169-177
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Incidence and prognostic significance of karyotypic subgroups in older patients with acute myeloid leukemia: the Swedish population-based experienceBlood Cancer Journal, 2014
- Inhibition of Mitochondrial Translation as a Therapeutic Strategy for Human Acute Myeloid LeukemiaCancer Cell, 2011
- Has there been progress in the treatment of older patients with acute myeloid leukemia?Best Practice & Research Clinical Haematology, 2010
- How I treat acute myeloid leukemiaBlood, 2010
- BCL2 gene polymorphism could predict the treatment outcomes in acute myeloid leukemia patientsLeukemia Research, 2010
- Cell DeathNew England Journal of Medicine, 2009
- Acute myeloid leukemia: Epidemiology and etiologyCancer, 2006
- Drug therapy for acute myeloid leukemiaBlood, 2005
- The relationship of patient age to the pathobiology of the clonal myeloid diseasesSeminars in Oncology, 2004
- ACUTE MYELOID LEUKEMIA: TREATMENT OVER 60Reviews in Clinical and Experimental Hematology, 2002